At this time, I would like to welcome everyone to the Biogen third quarter 2024 earnings call and business update. [Operator ...

Analyst Terence Flynn from Morgan Stanley maintained a Hold rating on Biogen (BIIB – Research Report) and keeping the price target at ...

Dr. Amato, you may begin your conference. Stephen Amato: Thank you. Good morning, and welcome to Biogen's third quarter 2024 earnings call. During this call, we'll make forward-looking statements ...

Dr. Amato, you may begin your conference. Thank you. Good morning, and welcome to Biogen's third quarter 2024 earnings call. During this call, we'll make forward-looking statements, which involve ...

Stephen Amato-- Interim Head of Investor Relations Thank you. Good morning, and welcome to Biogen's third quarter 2024 earnings call. During this call, we'll make forward-looking statements ...